Aclaris Therapeutics(ACRS)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

ACRS Aclaris Therapeutics

盘后交易 02-11 16:21:24 EST

3.39

-0.26

-7.12%

盘后3.39

+0.000.00%

16:10 EST

最高3.68	最低3.35	成交量82.15万
今开3.65	昨收3.65	日振幅8.85%
总市值3.67亿	流通市值2.46亿	总股本1.08亿
成交额282.15万	换手率1.13%	流通股本7,265万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"ACRS","market":"US","secType":"STK","nameCN":"Aclaris Therapeutics","latestPrice":3.39,"timestamp":1770843600000,"preClose":3.65,"halted":0,"volume":821517,"hourTrading":{"tag":"盘后","latestPrice":3.39,"preClose":3.39,"latestTime":"16:10 EST","volume":3009,"amount":10200.51,"timestamp":1770844204760,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":-0.07123287671232871,"floatShares":72651442,"shares":108345239,"eps":-1.3076717,"marketStatus":"盘后交易","change":-0.26,"latestTime":"02-11 16:21:24 EST","open":3.65,"high":3.675,"low":3.352,"amount":2821524.78201,"amplitude":0.088493,"askPrice":3.82,"askSize":10000,"bidPrice":3.35,"bidSize":200,"shortable":3,"etf":0,"ttmEps":-1.3076717,"tradingStatus":3,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1770858000000},"marketStatusCode":4,"adr":0,"adrRate":0,"listingDate":1444190400000,"exchange":"NASDAQ","adjPreClose":3.65,"preHourTrading":{"tag":"盘前","latestPrice":3.65,"preClose":3.65,"latestTime":"09:29 EST","volume":9062,"amount":33958.6968446,"timestamp":1770820199691,"change":0,"changeRate":0,"amplitude":0.032301},"postHourTrading":{"tag":"盘后","latestPrice":3.39,"preClose":3.39,"latestTime":"16:10 EST","volume":3009,"amount":10200.51,"timestamp":1770844204760,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.892809,"impliedVol":0.667,"impliedVolPercentile":0.1434},"requestUrl":"/m/hq/s/ACRS/wiki","defaultTab":"wiki","newsList":[{"id":"1192452610","title":"Aclaris Therapeutics新型Itk/Jak3抑制剂ATI-2138在验证性斑秃小鼠模型中展现快速且持久的毛发再生效果","url":"https://stock-news.laohu8.com/highlight/detail?id=1192452610","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1192452610?lang=zh_cn&edition=full","pubTime":"2026-01-27 19:56","pubTimestamp":1769514971,"startTime":"0","endTime":"0","summary":"Aclaris Therapeutics公司研发的新型Itk/Jak3抑制剂ATI-2138，在经科学验证的斑秃小鼠模型中，成功实现了快速且持久的毛发再生。这一重要发现为斑秃治疗领域带来了新的希望，展示了该候选药物在调节免疫系统以促进毛发生长方面的显著潜力。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","ACRS"],"gpt_icon":0},{"id":"1161570748","title":"Aclaris Therapeutics启动新型双特异性抗体ATI-052治疗特应性皮炎的1B期概念验证试验","url":"https://stock-news.laohu8.com/highlight/detail?id=1161570748","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1161570748?lang=zh_cn&edition=full","pubTime":"2026-01-12 19:56","pubTimestamp":1768218991,"startTime":"0","endTime":"0","summary":"Aclaris Therapeutics（股票代码：ACRS）已正式启动其创新双特异性抗体ATI-052针对特应性皮炎（AD）的1B期概念验证临床试验。该试验旨在评估ATI-052在患者中的初步疗效与安全性，标志着公司在该治疗领域的重要进展。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ACRS","BK4007"],"gpt_icon":0},{"id":"1128928153","title":"Aclaris Therapeutics公布ATI-052抗TSLP/IL-4Rα双特异性抗体1a期试验中期积极结果，支持加速临床开发","url":"https://stock-news.laohu8.com/highlight/detail?id=1128928153","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1128928153?lang=zh_cn&edition=full","pubTime":"2026-01-06 19:59","pubTimestamp":1767700758,"startTime":"0","endTime":"0","summary":"Aclaris Therapeutics今日宣布，其创新药物ATI-052——一款靶向TSLP/IL-4Rα的双特异性抗体，在1a期临床试验中取得了积极的中期结果。这一关键进展为后续的加速临床开发计划提供了有力支持。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ACRS","BK4007"],"gpt_icon":0},{"id":"1121658047","title":"Aclaris Therapeutics第三季度净损失1461.4万美元，符合IBES预期的1580万美元亏损","url":"https://stock-news.laohu8.com/highlight/detail?id=1121658047","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1121658047?lang=zh_cn&edition=full","pubTime":"2025-11-20 00:57","pubTimestamp":1763571421,"startTime":"0","endTime":"0","summary":"11月6日 - Aclaris Therapeutics第三季度收入为329.9万美元，高于IBES预期的159万美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ACRS","BK4007"],"gpt_icon":0},{"id":"2517461224","title":"Aclaris Therapeutics(ACRS.US)获Scotiabank首次覆盖，给予跑赢大盘评级, 目标价15.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2517461224","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517461224?lang=zh_cn&edition=full","pubTime":"2025-03-08 06:25","pubTimestamp":1741386325,"startTime":"0","endTime":"0","summary":"Aclaris Therapeutics(ACRS.US)获Scotiabank首次覆盖，给予跑赢大盘评级, 目标价15.00美元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/03/08062548605320.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["LENZ","ACRS"],"gpt_icon":0},{"id":"1163304129","title":"Aclaris Therapeutics 2024年第四季度GAAP每股收益$(1.01)低于预期$(0.24)，销售额$9.21M高于预期$2.11M","url":"https://stock-news.laohu8.com/highlight/detail?id=1163304129","media":"财报速递","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1163304129?lang=zh_cn&edition=full","pubTime":"2025-02-27 20:20","pubTimestamp":1740658810,"startTime":"0","endTime":"0","summary":"Aclaris Therapeutics报告称，季度每股亏损$，低于分析师一致预期的$，差距高达320.83%。公司报告季度销售额为$9.21百万，高于分析师一致预期的$2.11百万，超出预期336.89%。相比去年同期的$17.57百万销售额下降了47.58%。以上内容来自Benzinga Earnings专栏，原文如下：$Aclaris Therapeutics$  reported quarterly losses of $ per share which missed the analyst consensus estimate of $ by 320.83 percent.  The company reported quarterly sales of $9.21 million which beat the analyst consensus estimate of $2.11 million by 336.89 percent.  This is a 47.58 percent decrease over sales of $17.57 million the same","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Aclaris Therapeutics 2024年第四季度GAAP每股收益$(1.01)低于预期$(0.24)，销售额$9.21M高于预期$2.11M","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ACRS"],"gpt_icon":0},{"id":"2512848955","title":"Aclaris Therapeutics, Inc.盘中异动 早盘急速上涨5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2512848955","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512848955?lang=zh_cn&edition=full","pubTime":"2025-02-19 23:41","pubTimestamp":1739979660,"startTime":"0","endTime":"0","summary":"北京时间2025年02月19日23时41分，Aclaris Therapeutics, Inc.股票出现波动，股价快速拉升5.00%。Aclaris Therapeutics, Inc.股票所在的生命科学行业中，整体涨幅为0.79%。其相关个股中，Prophase Labs, Inc.、Grail, Inc.、Prenetics Global Limited C/Wts 18/05/2027 涨幅较大，Prophase Labs, Inc.、Mainz Biomed N.V.、Ispecimen Inc.较为活跃，换手率分别为52.27%、4.78%、2.59%，振幅较大的相关个股有Prenetics Global Limited C/Wts 18/05/2027 、Prophase Labs, Inc.、Genedx Holdings Corp C/Wts 22/07/2026 ，振幅分别为34.78%、18.22%、12.36%。Aclaris Therapeutics, Inc.公司简介：Aclaris Therapeutics Inc 是一家在美国运营的临床阶段生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250219234100a24c0945&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250219234100a24c0945&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ACRS","BK4007","LENZ","BK4139"],"gpt_icon":0},{"id":"2511006615","title":"Aclaris Therapeutics, Inc.盘中异动 下午盘快速上涨5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2511006615","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2511006615?lang=zh_cn&edition=full","pubTime":"2025-02-15 02:39","pubTimestamp":1739558372,"startTime":"0","endTime":"0","summary":"北京时间2025年02月15日02时39分，Aclaris Therapeutics, Inc.股票出现波动，股价急速拉升5.00%。截至发稿，该股报2.31美元/股，成交量19.5529万股，换手率0.18%，振幅5.91%。Aclaris Therapeutics, Inc.股票所在的生命科学行业中，整体涨幅为0.04%。其相关个股中，Neuronetics, Inc.、燃石医学、Personalis, Inc.涨幅较大，Prophase Labs, Inc.、Mainz Biomed N.V.、Grail, Inc.较为活跃，换手率分别为38.46%、12.52%、5.82%，振幅较大的相关个股有Bioaffinity Technologies Inc C/Wts 07/09/2027 、Prophase Labs, Inc.、Personalis, Inc.，振幅分别为46.14%、36.74%、20.04%。Aclaris Therapeutics, Inc.公司简介：Aclaris Therapeutics Inc 是一家在美国运营的临床阶段生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250215023932a24635f2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250215023932a24635f2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","ACRS","BK4007"],"gpt_icon":0},{"id":"2510623338","title":"Aclaris Therapeutics, Inc.盘中异动 股价大跌5.02%报2.27美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2510623338","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2510623338?lang=zh_cn&edition=full","pubTime":"2025-02-11 22:45","pubTimestamp":1739285107,"startTime":"0","endTime":"0","summary":"北京时间2025年02月11日22时45分，Aclaris Therapeutics, Inc.股票出现波动，股价急速下跌5.02%。截至发稿，该股报2.27美元/股，成交量2.1301万股，换手率0.02%，振幅3.35%。Aclaris Therapeutics, Inc.股票所在的生命科学行业中，整体跌幅为0.35%。Aclaris Therapeutics, Inc.公司简介：Aclaris Therapeutics Inc 是一家在美国运营的临床阶段生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250211224507961f4a63&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250211224507961f4a63&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","BK4007","ACRS"],"gpt_icon":0},{"id":"2509207333","title":"Aclaris Therapeutics, Inc.盘中异动 下午盘股价大跌5.64%","url":"https://stock-news.laohu8.com/highlight/detail?id=2509207333","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2509207333?lang=zh_cn&edition=full","pubTime":"2025-02-07 02:02","pubTimestamp":1738864933,"startTime":"0","endTime":"0","summary":"北京时间2025年02月07日02时02分，Aclaris Therapeutics, Inc.股票出现波动，股价大幅下跌5.64%。Aclaris Therapeutics, Inc.股票所在的生命科学行业中，整体跌幅为0.94%。其相关个股中，Neuronetics, Inc.、Endra Life Sciences Inc.、Genedx Holdings Corp C/Wts 22/07/2026 涨幅较大，Ispecimen Inc.、Mainz Biomed N.V.、Inotiv, Inc.较为活跃，换手率分别为14.95%、12.62%、3.97%，振幅较大的相关个股有Bioaffinity Technologies Inc C/Wts 07/09/2027 、Mainz Biomed N.V.、Prophase Labs, Inc.，振幅分别为25.50%、14.00%、13.63%。Aclaris Therapeutics, Inc.公司简介：Aclaris Therapeutics Inc 是一家在美国运营的临床阶段生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250207020214abc4fedb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250207020214abc4fedb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ACRS","BK4007","LENZ"],"gpt_icon":0},{"id":"2509646029","title":"Aclaris Therapeutics, Inc.盘中异动 下午盘股价大涨5.21%","url":"https://stock-news.laohu8.com/highlight/detail?id=2509646029","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2509646029?lang=zh_cn&edition=full","pubTime":"2025-02-05 02:36","pubTimestamp":1738694213,"startTime":"0","endTime":"0","summary":"北京时间2025年02月05日02时36分，Aclaris Therapeutics, Inc.股票出现波动，股价大幅拉升5.21%。Aclaris Therapeutics, Inc.股票所在的生命科学行业中，整体跌幅为0.78%。其相关个股中，Exagen Inc.、Bioaffinity Technologies Inc C/Wts 07/09/2027 、Neuronetics, Inc.涨幅较大，Mainz Biomed N.V.、Ispecimen Inc.、Exagen Inc.较为活跃，换手率分别为14.40%、10.08%、5.13%，振幅较大的相关个股有Bioaffinity Technologies Inc C/Wts 07/09/2027 、Exagen Inc.、安奈特保险，振幅分别为28.48%、26.31%、22.56%。Aclaris Therapeutics, Inc.公司简介：Aclaris Therapeutics Inc 是一家在美国运营的临床阶段生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250205023654987a702c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250205023654987a702c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ACRS","LENZ","BK4007","BK4139"],"gpt_icon":0},{"id":"2507965738","title":"Aclaris Therapeutics, Inc.盘中异动 股价大涨6.28%","url":"https://stock-news.laohu8.com/highlight/detail?id=2507965738","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2507965738?lang=zh_cn&edition=full","pubTime":"2025-01-31 22:30","pubTimestamp":1738333847,"startTime":"0","endTime":"0","summary":"北京时间2025年01月31日22时30分，Aclaris Therapeutics, Inc.股票出现波动，股价快速上涨6.28%。截至发稿，该股报2.54美元/股，成交量5.433万股，换手率0.05%，振幅0.42%。Aclaris Therapeutics, Inc.股票所在的生命科学行业中，整体涨幅为0.00%。其相关个股中，Mainz Biomed N.V.、Aclaris Therapeutics, Inc.、Oncocyte Corporation涨幅较大，Mainz Biomed N.V.、Ispecimen Inc.、T2 Biosystems, Inc.较为活跃，换手率分别为0.53%、0.21%、0.16%，振幅较大的相关个股有Personalis, Inc.、Grail, Inc.、赛默飞世尔，振幅分别为1.87%、1.43%、1.10%。Aclaris Therapeutics, Inc.公司简介：Aclaris Therapeutics Inc 是一家在美国运营的临床阶段生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501312230479614ea84&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501312230479614ea84&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ACRS","BK4007","BK4139","LENZ"],"gpt_icon":0},{"id":"2503066574","title":"Aclaris Therapeutics, Inc.盘中异动 股价大跌5.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2503066574","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2503066574?lang=zh_cn&edition=full","pubTime":"2025-01-14 22:56","pubTimestamp":1736866610,"startTime":"0","endTime":"0","summary":"北京时间2025年01月14日22时56分，Aclaris Therapeutics, Inc.股票出现异动，股价大幅跳水5.04%。截至发稿，该股报2.36美元/股，成交量6.5676万股，换手率0.06%，振幅5.65%。Aclaris Therapeutics, Inc.股票所在的生命科学行业中，整体涨幅为0.13%。其相关个股中，Atlantic International Corp.、Neogenomics, Inc.、因美纳涨幅较大，Neuronetics, Inc.、T2 Biosystems, Inc.、Mainz Biomed N.V.较为活跃，换手率分别为1.03%、0.88%、0.54%，振幅较大的相关个股有Neuronetics, Inc.、T2 Biosystems, Inc.、Atlantic International Corp.，振幅分别为11.92%、10.63%、9.67%。Aclaris Therapeutics, Inc.公司简介：Aclaris Therapeutics Inc 是一家在美国运营的临床阶段生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250114225650a221be7c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250114225650a221be7c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","ACRS","BK4007"],"gpt_icon":0},{"id":"2502898737","title":"Aclaris Therapeutics, Inc.盘中异动 快速跳水5.08%报2.34美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2502898737","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2502898737?lang=zh_cn&edition=full","pubTime":"2025-01-10 23:10","pubTimestamp":1736521809,"startTime":"0","endTime":"0","summary":"北京时间2025年01月10日23时10分，Aclaris Therapeutics, Inc.股票出现波动，股价快速下挫5.08%。Aclaris Therapeutics, Inc.股票所在的生命科学行业中，整体跌幅为0.26%。其相关个股中，Bioaffinity Technologies Inc C/Wts 07/09/2027 、Neuronetics, Inc.、Volitionrx Limited涨幅较大，Applied Dna Sciences, Inc.、Ispecimen Inc.、T2 Biosystems, Inc.较为活跃，换手率分别为3.18%、1.95%、1.80%，振幅较大的相关个股有Bioaffinity Technologies Inc C/Wts 07/09/2027 、Check-Cap Ltd.、Neogenomics, Inc.，振幅分别为20.93%、14.26%、12.09%。Aclaris Therapeutics, Inc.公司简介：Aclaris Therapeutics Inc 是一家在美国运营的临床阶段生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501102310099861f269&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501102310099861f269&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ACRS","BK4007","BK4139","LENZ"],"gpt_icon":0},{"id":"2501525149","title":"Aclaris Therapeutics, Inc.盘中异动 股价大跌5.38%","url":"https://stock-news.laohu8.com/highlight/detail?id=2501525149","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2501525149?lang=zh_cn&edition=full","pubTime":"2025-01-06 23:30","pubTimestamp":1736177406,"startTime":"0","endTime":"0","summary":"北京时间2025年01月06日23时30分，Aclaris Therapeutics, Inc.股票出现波动，股价快速下挫5.38%。截至发稿，该股报2.46美元/股，成交量14.1031万股，换手率0.13%，振幅6.54%。Aclaris Therapeutics, Inc.股票所在的生命科学行业中，整体涨幅为1.92%。其相关个股中，Guardant Health, Inc.、Inotiv, Inc.、Grail, Inc.涨幅较大，Check-Cap Ltd.、Ispecimen Inc.、Applied Dna Sciences, Inc.较为活跃，换手率分别为15.84%、5.52%、4.95%，振幅较大的相关个股有Check-Cap Ltd.、Applied Dna Sciences, Inc.、Prophase Labs, Inc.，振幅分别为24.86%、8.95%、8.41%。Aclaris Therapeutics, Inc.公司简介：Aclaris Therapeutics Inc 是一家在美国运营的临床阶段生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250106233006a217a42f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250106233006a217a42f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","ACRS","BK4139","BK4007"],"gpt_icon":0},{"id":"2500397451","title":"Aclaris Therapeutics, Inc.盘中异动 股价大涨5.24%报2.61美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2500397451","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2500397451?lang=zh_cn&edition=full","pubTime":"2025-01-03 00:49","pubTimestamp":1735836566,"startTime":"0","endTime":"0","summary":"北京时间2025年01月03日00时49分，Aclaris Therapeutics, Inc.股票出现波动，股价急速拉升5.24%。Aclaris Therapeutics, Inc.股票所在的生命科学行业中，整体涨幅为0.58%。其相关个股中，Prenetics Global Limited C/Wts 18/05/2027 、Personalis, Inc.、Applied Dna Sciences, Inc.涨幅较大，Applied Dna Sciences, Inc.、Ispecimen Inc.、Endra Life Sciences Inc.较为活跃，换手率分别为14.71%、5.16%、1.78%，振幅较大的相关个股有Applied Dna Sciences, Inc.、Check-Cap Ltd.、Personalis, Inc.，振幅分别为26.18%、18.55%、16.78%。Aclaris Therapeutics, Inc.公司简介：Aclaris Therapeutics Inc 是一家在美国运营的临床阶段生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250103004926985919f7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250103004926985919f7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ACRS","BK4007","LENZ","BK4139"],"gpt_icon":0},{"id":"2495252615","title":"Aclaris Therapeutics, Inc.盘中异动 早盘股价大跌5.64%报2.58美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2495252615","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2495252615?lang=zh_cn&edition=full","pubTime":"2024-12-30 22:35","pubTimestamp":1735569327,"startTime":"0","endTime":"0","summary":"北京时间2024年12月30日22时35分，Aclaris Therapeutics, Inc.股票出现异动，股价急速下挫5.64%。截至发稿，该股报2.58美元/股，成交量5.087万股，换手率0.05%，振幅6.01%。Aclaris Therapeutics, Inc.股票所在的生命科学行业中，整体跌幅为0.74%。其相关个股中，Oncocyte Corporation、Prophase Labs, Inc.、T2 Biosystems, Inc.涨幅较大，Ispecimen Inc.、Applied Dna Sciences, Inc.、T2 Biosystems, Inc.较为活跃，换手率分别为1.16%、0.88%、0.84%，振幅较大的相关个股有Oncocyte Corporation、Prophase Labs, Inc.、Inotiv, Inc.，振幅分别为10.90%、7.17%、7.06%。Aclaris Therapeutics, Inc.公司简介：Aclaris Therapeutics Inc 是一家在美国运营的临床阶段生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241230223527a20f2c2e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241230223527a20f2c2e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ACRS","BK4139","BK4007","LENZ"],"gpt_icon":0},{"id":"2494381222","title":"Aclaris Therapeutics, Inc.盘中异动 快速下挫5.15%报2.77美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2494381222","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2494381222?lang=zh_cn&edition=full","pubTime":"2024-12-27 23:17","pubTimestamp":1735312624,"startTime":"0","endTime":"0","summary":"北京时间2024年12月27日23时17分，Aclaris Therapeutics, Inc.股票出现波动，股价快速跳水5.15%。截至发稿，该股报2.77美元/股，成交量11.1216万股，换手率0.10%，振幅6.99%。Aclaris Therapeutics, Inc.股票所在的生命科学行业中，整体跌幅为0.26%。其相关个股中，Endra Life Sciences Inc.、Prenetics Global Limited C/Wts 18/05/2027 、Prophase Labs, Inc.涨幅较大，Ispecimen Inc.、Check-Cap Ltd.、T2 Biosystems, Inc.较为活跃，换手率分别为5.88%、2.15%、1.36%，振幅较大的相关个股有T2 Biosystems, Inc.、Check-Cap Ltd.、Inotiv, Inc.，振幅分别为13.66%、12.61%、9.37%。Aclaris Therapeutics, Inc.公司简介：Aclaris Therapeutics Inc 是一家在美国运营的临床阶段生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241227231705a20c0834&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241227231705a20c0834&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ACRS","BK4007","LENZ","BK4139"],"gpt_icon":0},{"id":"2493669767","title":"Aclaris Therapeutics, Inc.盘中异动 早盘股价大涨13.97%","url":"https://stock-news.laohu8.com/highlight/detail?id=2493669767","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2493669767?lang=zh_cn&edition=full","pubTime":"2024-12-23 22:33","pubTimestamp":1734964394,"startTime":"0","endTime":"0","summary":"北京时间2024年12月23日22时33分，Aclaris Therapeutics, Inc.股票出现波动，股价急速上涨13.97%。截至发稿，该股报3.10美元/股，成交量17.5118万股，换手率0.16%，振幅9.19%。Aclaris Therapeutics, Inc.股票所在的生命科学行业中，整体跌幅为0.24%。其相关个股中，Aclaris Therapeutics, Inc.、Personalis, Inc.、Applied Dna Sciences, Inc.涨幅较大，Ispecimen Inc.、Mainz Biomed N.V.、Applied Dna Sciences, Inc.较为活跃，换手率分别为2.55%、1.00%、0.82%，振幅较大的相关个股有Personalis, Inc.、Aclaris Therapeutics, Inc.、Volitionrx Limited，振幅分别为10.09%、9.22%、7.90%。Aclaris Therapeutics, Inc.公司简介：Aclaris Therapeutics Inc 是一家在美国运营的临床阶段生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241223223316a2050b1f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241223223316a2050b1f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","ACRS","BK4139","BK4007"],"gpt_icon":0},{"id":"2492101665","title":"Aclaris Therapeutics, Inc.盘中异动 股价大跌5.36%","url":"https://stock-news.laohu8.com/highlight/detail?id=2492101665","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492101665?lang=zh_cn&edition=full","pubTime":"2024-12-20 01:21","pubTimestamp":1734628860,"startTime":"0","endTime":"0","summary":"北京时间2024年12月20日01时21分，Aclaris Therapeutics, Inc.股票出现波动，股价大幅下跌5.36%。Aclaris Therapeutics, Inc.股票所在的生命科学行业中，整体跌幅为0.02%。其相关个股中，Personalis, Inc.、Mainz Biomed N.V.、Bioaffinity Technologies, Inc.涨幅较大，Ispecimen Inc.、Applied Dna Sciences, Inc.、Mainz Biomed N.V.较为活跃，换手率分别为38.86%、13.99%、10.44%，振幅较大的相关个股有Fresh2 Group Limited、Personalis, Inc.、Prenetics Global Limited C/Wts 18/05/2027 ，振幅分别为34.78%、32.58%、23.53%。Aclaris Therapeutics, Inc.公司简介：Aclaris Therapeutics Inc 是一家在美国运营的临床阶段生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241220012100984cdbe8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241220012100984cdbe8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","ACRS","BK4007"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.aclaristx.com","stockEarnings":[{"period":"1week","weight":0.0519},{"period":"1month","weight":0.3826},{"period":"3month","weight":0.5145},{"period":"6month","weight":1.1598},{"period":"1year","weight":0.5272},{"period":"ytd","weight":0.2126}],"compareEarnings":[{"period":"1week","weight":0.0038},{"period":"1month","weight":-0.0028},{"period":"3month","weight":0.0128},{"period":"6month","weight":0.0731},{"period":"1year","weight":0.1443},{"period":"ytd","weight":0.015}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Aclaris Therapeutics, Inc.于2012年7月在美国特拉华州成立。该公司是一家临床阶段的生物制药公司，专注于开发免疫炎症疾病的新型候选药物。","yearOnYearQuotes":[{"month":1,"riseRate":0.363636,"avgChangeRate":0.145543},{"month":2,"riseRate":0.454545,"avgChangeRate":-0.018516},{"month":3,"riseRate":0.4,"avgChangeRate":-0.054834},{"month":4,"riseRate":0.4,"avgChangeRate":-0.010072},{"month":5,"riseRate":0.5,"avgChangeRate":-0.043272},{"month":6,"riseRate":0.6,"avgChangeRate":-0.004956},{"month":7,"riseRate":0.6,"avgChangeRate":0.009999},{"month":8,"riseRate":0.5,"avgChangeRate":-0.019617},{"month":9,"riseRate":0.4,"avgChangeRate":0.026634},{"month":10,"riseRate":0.4,"avgChangeRate":0.132278},{"month":11,"riseRate":0.363636,"avgChangeRate":0.075295},{"month":12,"riseRate":0.727273,"avgChangeRate":0.092435}],"exchange":"NASDAQ","name":"Aclaris Therapeutics","nameEN":"Aclaris Therapeutics"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Aclaris Therapeutics(ACRS)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Aclaris Therapeutics(ACRS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Aclaris Therapeutics,ACRS,Aclaris Therapeutics股票,Aclaris Therapeutics股票老虎,Aclaris Therapeutics股票老虎国际,Aclaris Therapeutics行情,Aclaris Therapeutics股票行情,Aclaris Therapeutics股价,Aclaris Therapeutics股市,Aclaris Therapeutics股票价格,Aclaris Therapeutics股票交易,Aclaris Therapeutics股票购买,Aclaris Therapeutics股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Aclaris Therapeutics(ACRS)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Aclaris Therapeutics(ACRS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}